Clinical Trial Update: Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing TIP (paclitaxel, ifosfamide, and cisplatin) with BEP (bleomycin, etoposide, and cisplatin) for previously untreated inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumors

Drugs mentioned

• Bleomycin (bleomycin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Germ Cell Tumors | Phase 2 | Status: ACTIVE_NOT_RECRUITING